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Background: Feedback inhibition of biosynthetic threonine deaminase (TD)
from Escherichia coli provided one of the earliest examples of protein-based
metabolic regulation. Isoleucine, the pathway end-product, and valine, the
product of a parallel pathway, serve as allosteric inhibitor and activator,
respectively. This enzyme is thus a useful model system for studying the
structural basis of allosteric control mechanisms.
Results: We report the crystal structure of TD at 2.8 Å resolution. The tetramer
has 222 symmetry, with C-terminal regulatory domains projecting out from a
core of catalytic PLP-containing N-terminal domains. The subunits, and
especially the regulatory domains, associate extensively to form dimers, which
associate less extensively to form the tetramer. Within the dimer, each monomer
twists approximately 150° around a thin neck between the domains to place its
catalytic domain adjacent to the regulatory domain of the other subunit. 
Conclusions: The structure of TD and its comparison with related structures
and other data lead to the tentative identification of the regulatory binding site
and revealed several implications for the allosteric mechanism. This work
prepares the way for detailed structure/function studies of the complex
allosteric behaviour of this enzyme. 
Introduction
The enzymology of control by feedback inhibition is a
well established tenet of biochemistry; metabolic regula-
tion is achieved through variations in the activity of oligo-
meric allosteric enzymes arising from ligand-promoted
changes in the interactions between their subunits [1].
Biosynthetic threonine deaminase from Escherichia coli
(distinguished from a biodegradative threonine deaminase
also present in E. coli) played a prominent role in the
development of this concept, due primarily to the work of
Umbarger, Changeux and colleagues [2,3]. Early work
using crude cell lysates established that threonine deami-
nase activity was end-product inhibited by isoleucine
[4–7]. Later enzymological studies provided initial exper-
imental support for the notion that different conforma-
tions of regulatory enzymes could be stabilized by ligand
binding to sites distinct from their active site [8–11].
These observations were influential to the development
of the seminal two-state model of allostery [12]. 
Threonine deaminase (threonine dehydratase; L-threo-
nine hydrolyase (deaminating); EC 4.2.1.16; TD) cat-
alyzes the committed step in branched chain amino acid
biosynthesis in plants and microorganisms: the pyridoxal
5¢ -phosphate (PLP)-dependent dehydration/deamination
of L-threonine (or L-serine) to 2-ketobutyrate (or pyru-
vate). End-product control by isoleucine and valine of the
sigmoidal a ,b -elimination reaction regulates carbon flow
through the pathway in order to maintain a proper balance
of metabolites for efficient protein synthesis. The enzyme
is a tetramer of identical 514-residue chains, and contains
four pyridoxal phosphate moieties [13]. This is particularly
interesting as of the several hundred PLP-dependent
enzymes of known sequence, TD is one of the few coop-
erative, feedback-regulated allosteric enzymes that utilize
this versatile cofactor. 
Binding studies using wild type and site-specific mutants of
TD have revealed four effector sites for isoleucine and
valine [14,15]. These studies led to the formulation of an
expanded two-state model for homotropic cooperativity in
TD in which substrates and analogs possess greater affinity
for the regulatory sites than for the active sites [16], suggest-
ing that the allosteric transition from the low activity T state
to the high activity R state occurs synergistically, in a pro-
gressive manner throughout the saturation curve. 
A fundamental goal of research on allosteric proteins is
to correlate the large changes in the activity of these
enzymes with changes in their structures [17,18]. TD has
been crystallized under several conditions, and three
forms have been characterized by X-ray diffraction [19]. In
this report, a 2.8 Å resolution structure of TD is described
for an unligated crystal form with a single chain in the
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asymmetric unit. As high-resolution structures are essen-
tial to resolving the nature of the subunit rearrangements
that are linked to allosteric transition(s), this work pro-
vides the starting point for structure/function studies of
the effects of ligand binding and the complex allosteric
behavior of this enzyme. 
Results
Quaternary structure
The overall shape of the TD tetramer is a prolate ellipsoid
(Figure 1), with three mutually perpendicular twofold
axes intersecting at the center; these axes will be called p,
q and r, as suggested in [20]. The four N-terminal catalytic
domains form the core of the tetramer, whereas the C-ter-
minal regulatory domains form the ends, lying along the r
axis. Quaternary contacts around the r dyad are the most
extensive, especially between the C-terminal regulatory
domains, with a smaller area of interaction along the p
dyad. There are no quaternary interactions by the q axis.
The tetramer therefore appears as a ‘dimer of dimers’ in
which each subunit interacts with two other subunits
along two strikingly different subunit interfaces. 
Polypeptide fold and domain organization
Each of the identical subunits of TD is organized into two
differently sized domains, in agreement with earlier genetic
studies [21–23]. A diagram of the secondary structure topol-
ogy of TD, as calculated by the program DSSP, [24] is pre-
sented in Figure 2. A larger N-terminal domain, which is
referred to as the catalytic domain as it contains the essen-
tial pyridoxal phosphate cofactor, consists of residues 1–320
and comprises two distinct but similar folding units, N1 and
N2. As can be seen in Figure 3, the N1 and N2 subdomains
each contain a central four-stranded, parallel b sheet with
flanking helices. While the N2 subdomain consists of a
single contiguous zone of sequence (residues 63–153), N1
is composed of an N2-like core (residues 160–313) with
an additional pair of antiparallel strands (residues 34–51)
extending the b sheet to six strands. The catalytic domain is
homologous (40 identities out of about 280 aligned residues
[25]) to the b subunit of tryptophan synthase from Salmo-
nella typhimurium, and the relation of the subdomains is
largely as described for that enzyme [26]. This relation and
homology are further described in the Discussion section. 
The C-terminal regulatory domain, comprising residues
321–514, folds as an eight-stranded antiparallel sheet with
helices on one side, and can be divided into two similar half
sheets related by approximate twofold symmetry. As can be
seen in Figure 3 (see also Figure 2), each of these half-
sheets has an ‘a +b plait’ folding topology [27]. In the
oligomer, two regulatory domains associate extensively to
form a spheroidal dimer with a diameter of about 50 Å. This
pairing of C-terminal domains places the helices on the
outside, with the two eight-stranded sheets close to the r
dyad but separated by an intervening layer. This layer is
formed by residues 411–432, which connect the two a +b
plait folding units. The zone of missing residues 481–496 is
on the exterior of the domain, in a position where a helix
would be expected in order to complete the second a +b
plait motif. Figure 4 presents a Ca trace of one TD subunit
in the context of the tetramer’s symmetry axes.
The catalytic and regulatory domains are connected by a
thin neck-like region. This narrow neck twists about 150°
around the r dyad with the result that each catalytic domain
is adjacent to a regulatory domain belonging to a different
subunit. This region of the structure, with its right-handed
overall twist, is dominated by helix 13 (residues 323–334).
Interestingly, except for contacts involving helix 13 itself,
there appear to be no contacts between catalytic and regula-
tory domains. Helix 13 makes several van der Waals and
ionic interactions with residues from the catalytic and reg-
ulatory domains, and associates closely with its r dyad
symmetry mate.
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Figure 1
The quaternary and tertiary structure of the TD tetramer. Each of the
four chains is shown in a distinct color. The length of the tetramer is
150 Å from top to bottom. The PLP cofactors within the catalytic N-
terminal domains are shown in yellow. The C-terminal regulatory
domains are at the top and bottom in this view. (Figure made using
Raster3D [55,56].)
Intersubunit interactions
Because cooperative ligand binding by allosteric proteins
can be energetically driven by changes in the interactions
between subunits, it is of interest to examine the nature of
the intersubunit interactions in the unligated conforma-
tion of TD. There are three unique subunit interfaces in
the tetramer. There is a relatively small region of contact
relating catalytic domains about the p dyad, there is a
larger, more complicated interface between catalytic
domains across the r dyad, and there is an extensive set of
interactions between regulatory domains, also about the r
dyad axis. 
The subunit interface along the p dyad is made up pri-
marily of residues from regular structure in three sections
of the polypeptide chain. Contacts include Leu17 and
Leu21 from the C-terminal region of helix 1, Leu171,
Gln175 and Ala178 from the C-terminal region of helix 7,
and residues Leu203 and Met204 from the C-terminal
region of helix 8. As can be seen in Figure 5, the area of
contact is relatively small, and primarily hydrophobic in
nature. The solvent accessible surface area buried at this
interface is approximately 730 Å2 (calculated by the
program ‘ms’ [28]), with interaction between two symme-
try-related Gln175 residues providing the chief polar
contact at the interface. Strikingly, substitution of Gln175
with either glutamate or aspartate results in the dissocia-
tion of the native tetramer into fully active dimeric
enzymes that retain cooperative ligand binding and feed-
back control (DC, DTG and EE, unpublished results). 
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Figure 2
Secondary structure and general organization
of one TD subunit. b Sheets are shown as
arrows and a helices as cylinders; the residue
numbers at the ends of the structural
elements are given. GGGG indicates the
tetraglycine loop (residues 188–191) that
coordinates the phosphate group of the PLP
cofactor. The catalytic domain is shown below
in blue and purple. The N1 subdomain is in
the lower right and the N2 subdomain in the
lower left. The regulatory domain is at the top
in magenta and orange. The missing zone
(residues 481–496) is indicated by a dotted
line. (Secondary structure assignments were
made using the program DSSP [24].)
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Structure
The subunit interface along the r dyad of the tetramer is
much more extensive and involves both the catalytic and
regulatory domains. The interface between the portion
of the chains that form the catalytic domain is limited to
a set of sidechains close to the r axis. As can be seen in
Figure 6, only the N1 subdomain is involved and there
is a preponderance of positively charged sidechains.
This part of the interface buries about 1100 Å2 of
surface area. In contrast to the interactions among the
catalytic domains, the interface between regulatory
domains is quite interdigitated, with the two adjacent
chains packing tightly together. Figure 7 shows the 30
sidechains that approach within 4 Å in this portion of the
interface. This is by far the most extensive domain–
domain interaction, burying about 2200 Å2 per domain
and involving numerous hydrophobes. 
Environment of pyridoxal phosphate and the putative
active site
As TD utilizes PLP as a cofactor for the conversion of
threonine to a -ketobutyrate, and genetic studies have
implicated several residues that contribute to catalysis
[22], it is of interest to examine the environment sur-
rounding the cofactor for clues to the substrate-binding
site. The PLP is wedged snugly between the N1 and N2
folding units of the catalytic domain (Figure 8), in a site
that is formed entirely by residues from a single subunit.
The coenzyme is observed bound to Lys62, in agreement
with previous chemical identification [16]. The cofactor is
sandwiched between the sidechain of Phe61 and the
mainchain of Gly241. Each of the PLP’s polar substituents
is coordinated by an appropriate enzyme functional group:
the pyridinium nitrogen is hydrogen bonded to the
sidechain of Ser315, the C3-hydroxyl group is hydrogen
bonded to the sidechain of Asn89, and the phosphate
group of PLP is coordinated by mainchain amides from
the tetraglycine loop (residues 188–191) at the N terminus
of helix 8 (see Figure 2). 
Crystal packing
The construction of the tetramer is unambiguous, due to
its close cyclic arrangement around only one of the four
unique 222 centers in the unit cell. Each monomer (the
asymmetric unit) contacts two others within its tetramer,
and also makes six contacts to neighboring subunits in the
crystal. The crystal contacts appear weak: each of the
three crystallographically unique lattice interactions
involves fewer than eight residues in total. Each of these
contacts is between the C-terminal domain of one
tetramer and the N-terminal domain of a neighboring
tetramer. There is a gap of about 15 Å between successive
tetramers along the crystallographic c direction (molecular
r axis), confirming the assignment of the tetramer
(because each dimer contacts only one other dimer along
its axis, the two contacting dimers must define the
tetramer). The body-centered crystal is formed by interac-
tions between identically oriented tetramers, where each
tetramer contacts all eight of its neighbors at (x – ½,
y – ½, z – ½). Crystal growth and morphology have been
described [19]. 
Discussion 
The structure of tetrameric TD advances efforts to
understand its mechanism of cooperative ligand binding
and allosteric control, and integrates several previous
observations concerning the structure and function of
homologous regulatory dehydratases and other PLP-
dependent enzymes. 
Some of the earliest descriptions of the structural attributes
of TD originated from studies of the sequences of repre-
sentative PLP-containing enzymes, which suggested that
TD would contain a fold that was similar to the b subunit
468 Structure 1998, Vol 6 No 4
Figure 3
TD dimer ribbon model. One chain is colored gray, while the other is
colored from blue to orange to indicate the sequence of the domains
as shown in Figure 2. The active site PLP cofactor (center of lower
domain) and Gln175 (bottom) are shown in ball-and-stick
representation. The three mutually perpendicular dyad axes are
depicted and the hydrogen-bonding interaction at the p dyad, involving
Gln175 (see Figure 5), is illustrated. Also labeled are the N1 and N2
subdomains of the catalytic domain. (Figure made using MOLSCRIPT
[57] and Raster3D [55,56].) 
of tryptophan synthase [21–23,29,30]. Although sequence
analysis suggests that a number of other PLP-dependent
enzymes appear to be in the same fold type II family [31],
thus far, a high-resolution structure has been available
only for tryptophan synthase. The structure of TD reveals
that the overall folding pattern of the N-terminal catalytic
domain is indeed identical to that of the b chain of trypto-
phan synthase [26]. These two PLP-containing catalysts
are composed of structurally similar subdomains of match-
ing topology, and possess a virtually complete set of
homologous secondary structure elements up to helix 13
(an exception is helix 9, residues 219–226, in TD). As seen
previously for the two subdomains of the b subunit of
tryptophan synthase, the smaller N2 subdomain in TD
occurs as an extended digression from the larger N1
portion, with an N-terminal extension along the cleft
between them. The Ca positions of the b subunit of tryp-
tophan synthase were superimposed on the catalytic
domain of TD using the program ALIGN [32]. Figure 9
shows that the majority of the secondary structure ele-
ments superimpose closely; the root mean square (rms)
deviation over 277 aligned Ca pairs is 1.8 Å. 
The similarity seen between these two proteins at the
chain and domain level is also apparent in their quaternary
structures. The twofold axis in the b 2 dimer of tryptophan
synthase corresponds to the r dyad in a catalytic domain
dimer of TD. The dimer interface is different for the two
proteins, however. The interface in the b 2 dimer is exten-
sive and involves both folding units, providing a broad,
relatively flat surface for dimerization. On the other hand,
the interface between catalytic domains of TD involves
relatively few residues, contributed exclusively by the N1
subdomain. Interestingly, in both the b 2 dimer and the
catalytic domain dimer of TD there is an arginine side-
chain involved in a close stacking interaction across the
dyad axis. This type of interaction, involving Arg379 in
the b subunit and Arg55 in TD, has been observed in
other dimeric structures [33]. 
In spite of the overall similarity within the catalytic
domain of TD to corresponding regions in the b chain of
tryptophan synthase, there are several significant differ-
ences. A unique structural feature in tryptophan synthase
is a molecular tunnel that is thought to conduct an indole
intermediate, generated in the a reaction, to the b site for
condensation with the PLP-bound amino acrylate [34–36].
This tunnel is formed partly by residues 260–310, which
adopt an extended loop with little regular secondary struc-
ture. No such tunnel is found in TD, where the corre-
sponding region (residues 215–250) has no resemblance or
sequence homology and also forms a somewhat unstruc-
tured loop. This loop (indicated by W in Figures 2 and 8)
forms one wall of the PLP-binding site and adjacent puta-
tive active-site cleft in TD. Another unusual feature of the
b -chain structure is that the last regular structural element,
Research Article  Allosteric threonine deaminase Gallagher et al. 469
Figure 4
Stereo view Ca trace of a single TD subunit.
The colors used are similar to those in
Figure 3, except that the PLP cofactor is
colored green. The view direction is the same
as for the colored subunit in Figure 3. Every
twentieth residue is marked with a dot; the
dyad axes are shown.
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Structure
helix 13, extends outwards away from the active site,
appearing to jut into solution [26]. The homologous struc-
tural region in TD, residues 323–334 (helix 13), forms the
neck that links the catalytic and regulatory domains. 
One of the interesting attributes of PLP-dependent
enzymes is their versatility: a single cofactor is used for
catalysis of a wide range of chemical reactions involving
amino acids. It is believed that the specificity and rate
increases seen for these enzymes are largely dictated by
the fold and the active site microenvironment of the par-
ticular catalyst [37]. Consequently, PLP-dependent
enzymes have frequently been grouped into families that
catalyze similar reactions in the hope of assessing their
propensity for adopting similar polypeptide folds. For
example, it has been proposed that the group of PLP-
dependent enzymes that catalyze b -replacement/elimi-
nation reactions, which includes TD and the b subunit of
tryptophan synthase and has been called the b family
[38] or type II [31], utilize the same overall fold
[30,31,38]. Indeed, many of the residues shown in
Figure 8 that are in the vicinity of the PLP in the TD
structure also appear to be strongly conserved in enzymes
of this family. These residues include Phe61 and Gly241,
that embrace the aromatic pyridine ring, and Asn89,
Ser315 and a tetraglycine loop (Gly188–Gly191) that
make hydrogen bonds with the cofactor. These results
strongly support the notion that the members of this family
of PLP-dependent enzymes adopt a similar structural
motif around the active site, and further suggest that the
family may exhibit homology at the level of tertiary and
perhaps even quaternary structure. 
The location of the substrate-binding site has not been
crystallographically determined. However, as threonine is
known to displace the e -amino group of Lys62 when
forming a Schiff base with PLP to initiate the catalytic cycle
[39], its binding site probably corresponds to a pocket adja-
cent to the observed PLP–Lys62 Schiff base linkage. In
addition, this interpretation is supported by early genetic
experiments that identified TD mutants with reduced
levels of catalytic activity [22]. Four auxotrophic mutants,
Lys62fi Glu, Ser86fi Gly, Trp153fi Tyr and Pro156fi Ser,
involve substitutions within 10 Å of the cofactor, and
suggest that they may affect activity by leading to a
decrease in substrate affinity or by decreasing the rates of
processing the PLP-bound catalytic intermediates. 
In addition to the structural similarities involving the cat-
alytic domain, the fold of the regulatory domain of TD
bears a striking resemblance to the regulatory serine-
binding domain of the allosteric enzyme D-3-phospho-
glycerate dehydrogenase (PGD) [40]. Each chain of this
tetrameric dehydrogenase has a C-terminal regulatory
domain with a single a +b plait, resembling one half of the
TD regulatory domain. Regulatory domains in two chains
of PGD associate with twofold symmetry to form an
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Figure 5
Dimer–dimer interactions at the p dyad. The sidechain of residue
Gln175 forms two hydrogen bonds with its symmetry mate. Also
emphasized are van der Waals contacts involving (from left to right in
the upper subunit) Leu21, Leu171 and Ala178. The view direction is
along the p dyad (see Figure 3). (Figure made using Raster3D
[55,56].)
Figure 6
The N-terminal catalytic domain viewed from the direction of the r dyad
interface, emphasizing residues involved in the interface. Mainchain
atoms are colored light purple (residues 5–160) and pink (residues
161–334). Sidechains within 4 Å of the dyad-related subunit are in
bright colors: blue for arginine, histidine and lysine; red for glutamate;
green for serine and asparagine; and orange for apolar residues. Other
sidechains are colored gray. The position of Gln175 is labeled for
orientational reference only. (Figure made using Raster3D [55,56].)
eight-stranded b sheet with four helices; this dimeric
structural unit resembles a monomeric regulatory domain
of TD. Thus, the approximate twofold symmetry in the
regulatory domain of TD, represented by the pseudo-
dyad at the top center in Figure 2, corresponds to true
molecular symmetry in the regulatory domain of PGD. 
The similarity of the fold of the TD regulatory domain with
that seen in PGD, and the fact that the reported structure of
the PGD domain is ligated with its regulatory effector
serine, provides a possible clue for the location of the
binding site(s) for isoleucine and valine in TD. Serine is
bound to the dimeric regulatory domain of PGD (at two
symmetry-related sites) on the dimer interface between the
sheet and helices [40,41]. As shown in Figure 10, the lower
of these sites corresponds to a location near the TD neck, at
the N terminus of helix 17 in TD, suggesting that residues
445–450 may be involved in effector binding. The results of
TD mutation studies lend additional support to this tenta-
tive identification of a TD effector site. A previously iso-
lated feedback-resistant mutant of TD, Leu447fi Phe,
binds only two of the normal four molecules of isoleucine or
valine [16]. Like the single Leu447fi Phe mutant, double
(Leu447fi Ala, Leu451fi Ala) and triple (Leu447fi Ala,
Leu451fi Ala, Leu454fi Ala) mutants in strongly conserved
helix 17 exhibit markedly altered regulatory properties.
These mutants are insensitive to feedback modifiers, with
immeasurably low affinities for isoleucine and valine (DC
and EE, unpublished results).
There are a number of unusual isoforms of TD, in particu-
lar the variants from Bacillus subtilis (PS Fink, personal
communication), Sulfolobus sulfartaricus (SJ Sandler, per-
sonal communication) and Corynebacterium glutamicum,
that contain only about 400 residues, but which are fully
regulated, allosteric tetramers [42]. Alignments of these
sequences with TD show that the homology among the
isoforms is strong throughout the catalytic domain, but
that the regulatory domain is only half as long as in E. coli.
These analyses can now be interpreted to indicate that the
variation in sequence alignment corresponds structurally
to the deletion of one of the four-stranded subdomains
from the regulatory domain of TD. Thus, (in a dimer)
only two a + b plait motifs may be necessary for feedback
regulation. However, it is unclear at this time how the
shorter, related threonine deaminases assemble into their
tetrameric quaternary structure. Either the arrangement of
the regulatory domains occurs in a side-by-side manner,
analogous to one chain of E. coli TD (as in PGD), or in a
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Figure 7
The C-terminal domain viewed from the direction of the r dyad
interface, emphasizing residues involved in the interface. The colors of
the sidechains are as described in Figure 6. In addition, Gly424 and
Gly425, which are located within 4 Å of the dyad mate, are colored
green. The locations of the protein C terminus and the neck region are
indicated. The view direction is close to that in Figure 4. (Figure made
using Raster3D [55,56].)
Figure 8
Environment of the PLP cofactor. Surrounding polypeptide regions are
colored blue and purple as in Figures 2–4; Lys62 and the cofactor are
colored green. Hydrogen-bonding partners to PLP and other key
residues are labeled (see text for details). The PLP ring is sandwiched
between Phe61 (brown) and Gly241 (belonging to the W loop in the
lower left foreground). The phosphate group is coordinated by all four
nitrogens from the tetraglycine loop (GGGG; residues 188–191) at
the N terminus of helix 8 (see Figure 2). (Figure made using Raster3D
[55,56].)
back-to-back orientation, resembling half of a dimeric reg-
ulatory unit of E. coli TD. 
The crystal structure of the unligated conformation of
TD does not as yet yield direct information on the transi-
tions that accompany increases in substrate affinity and
activity. Indeed, the structure raises numerous questions.
Does the unligated structure reported here correspond to
the low activity or T state? Or, following the nomencla-
ture for other PLP-dependent enzymes, is the structure
described here the open form? Is the open form equiva-
lent to the T state? If so, then when the active sites are
occupied by substrate analogs, is TD in a ‘closed’ form,
as has been described for other PLP-dependent enzymes
[43–45], and does this structure correspond to the high
activity R state? In light of the observed shifts in the sig-
moidal kinetics promoted by ligand binding to TD, to
what extent will the two-state model apply to the allo-
steric conformations adopted by this enzyme? In an
effort to address these questions and gain insight into
possible structural rearrangements that may result from
the conversion from the low activity to high activity con-
formation, a comparison of the catalytic domain of TD
with the structurally similar, PLP-containing b subunit of
tryptophan synthase was undertaken. This qualitative
analysis is facilitated by the extensive structural informa-
tion available for tryptophan synthase in the absence [26]
and presence of substrates and analogs [46] and various
essential monovalent cations [47]. 
A structural transition occurs in tryptophan synthase in
which the two subdomains of the b subunit close around
the active site in the presence of ligands [46]. If a similar
movement of homologous domains occurs when TD
binds active site ligands, this level of structural reorgani-
zation would be likely to affect the local interactions
about the p subunit axis and, thus, the communication
between dimers that gives rise to the observed homo-
tropic effects. Moreover, the proximity of the active site
and the putative effector site to helix 13 suggests that the
neck could be a focus of structural rearrangement in the
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Figure 9
Superposition [32] of the TD catalytic domain (residues 5–336, in
green) and the tryptophan synthase b subunit (purple). The PLP sites
are virtually identical; only one is shown (yellow, near middle of
structure). The view direction is similar to that in Figure 8. The
respective dyads are indicated by the long thin cylinders on the right
(i.e. the isolated green cylinder is the TD r dyad). Most of the elements
superpose closely; the greatest deviations are at the C termini and in
the region that includes the N termini and the W loops (upper left; see
text). The tryptophan synthase a subunit would be on the left in this
view, and the TD regulatory domain would be above the page. (Figure
made using Raster3D [55,56].)
Figure 10
Superposition [32] of the phosphoglycerate dehydrogenase (PGD)
and TD regulatory domains. The PGD dimeric domain, in cyan and
green, has crystallographic dyad symmetry and binds two regulatory
serine molecules (bright green). The eight-stranded TD regulatory
domain is colored in magenta and orange, as in Figures 2–4. The
direction of view is close to that of the gray subunit in Figure 3 (i.e. the
r dyad is behind the molecule). The black spheres show the start and
end of the missing zone (residues 481–496) in TD the structure of
which may be similar to the rightmost PGD helix. The TD effector site
may correspond to the lower PGD serine site (see text for details).
(Figure made using MOLSCRIPT [57].)
C
TD Neck
TD C
N
C
N
Structure
allosteric transition. In particular, the dimeric regulatory
domain could rotate with respect to the core of the cat-
alytic domain, through a change in the twist of the neck,
and this could affect the accessibility of the active site
and/or the open/closed status of the catalytic domain. It is
possible that aspects of both of these models may account
for the molecular communication among domains that
gives rise to cooperative ligand binding and feedback reg-
ulation in TD. Additional biochemical and structural
work will be needed to resolve these issues. 
Biological implications
Control of carbon flow into isoleucine and valine in
plants and microorganisms is achieved in part by
allosteric regulation of biosynthetic threonine deaminase
(TD). TD catalyzes the pyridoxal phosphate (PLP)-
dependent dehydration/deamination of threonine (and
serine) to yield 2-ketobutyrate (and pyruvate) in a con-
trolled fashion. The initial velocity of the reaction is a
sigmoidal function of substrate concentration, and the
sigmoidal kinetics are shifted markedly in the presence
of isoleucine and valine, end-products of the pathway.
Isoleucine is an allosteric inhibitor, while valine is an
allosteric activator of the enzyme-catalyzed reaction.
TD is a tetramer of identical polypeptide chains contain-
ing 514 amino acid residues. The structure of the
enzyme revealed by X-ray crystallography at 2.8 Å res-
olution shows that the tetramer has 222 symmetry, and
that each subunit is composed of two well defined
domains. The C-terminal regulatory domains project
outwards from a central core of four N-terminal cat-
alytic domains. The essential PLP cofactor is located
between two lobes of the catalytic domain and identifies
the active site. A number of residues surrounding the
cofactor are strongly conserved in other PLP-dependent
enzymes that similarly catalyze b -replacement/elimina-
tion reactions, suggesting a common structural frame-
work for this family of enzymes. 
The catalytic domain of TD is similar to the PLP-con-
taining b subunit of tryptophan synthase, while the fold
of the regulatory effector domain resembles that of
allosteric phosphoglycerate dehydrogenase. Comparison
with the serine-ligated dehydrogenase structure suggests
that the allosteric effector site in TD may involve helix
17. This observation is in agreement with the previous
identification of mutations in helix 17 that disrupt effec-
tor binding. 
The catalytic and regulatory domains of TD are con-
nected by a thin neck formed by helix 13 and its dyad
mate. Strikingly, there are no contacts between the cat-
alytic and regulatory domains except those involving
helix 13, which suggests it may be a crucial structural
region for the allosteric transition. Consideration of
ligand-promoted domain movements in the homologous
b subunit of tryptophan synthase, and the modular
organization of the structural domains for catalysis and
regulation in TD, suggests possible rigid-body domain
rearrangements that may be involved in cooperative
ligand binding and feedback regulation. Detailed struc-
ture/function studies can now be undertaken to investi-
gate these issues and to probe the molecular basis for the
allosteric transition. 
Materials and methods
General methods
TD was prepared as described previously [13,15] and crystallization,
diffraction at pH 7.2 and data processing were as described in [19].
Single isomorphous replacement with anomalous scattering (SIRAS)
phase calculation utilized the PHASES suite [48] as previously described
[19]. Solvent-leveled [49] SIRAS maps revealed the domain structure
and enabled tracing of the chain in the N-terminal catalytic domain
(residues 1–320). The SIRAS map of the C-terminal regulatory domain,
however, was uninterpretable. This domain (residues 330–514) pro-
trudes out from the catalytic domain core and appears to be inherently
less well ordered. In addition, the regulatory domain contains the
uranyl-binding site with its associated local nonisomorphism and
Fourier artifacts. 
Structure factor manipulations
When the catalytic domain had been built, it was used in a cyclic
phase-refinement procedure to improve maps of the regulatory domain.
The procedure, which we call iterative map recombination (IMR), was
as follows. Coordinates for the catalytic domain were Fourier-trans-
formed into structure factors representing this domain. A premise of
the IMR method is that these structure factors are sufficiently accurate
to enable phase improvement over the solvent-flattened SIRAS phases.
Next, the envelope of the unbuilt regulatory domain was defined as a
mask, and this mask was used to extract the regulatory domain region
from the SIRAS map. The extracted map region was transformed into
structure factors corresponding to the regulatory domain. The N-termi-
nal catalytic domain and C-terminal regulatory domain structure factors
were then scaled according to the relative sizes of the domains and
vectorially added to give new estimates of the total phase. These new
phases were combined with the solvent-leveled SIRAS phases to give
improved phases, a new map was calculated, and the cycle was
repeated. At each iteration, the same catalytic domain structure factors
were used, and the same regulatory domain mask was used, but the
maps in the regulatory domain region gradually improved. After ten
cycles using fixed catalytic domain coordinates, the catalytic domain
was refined in X-PLOR [50] using partial structure factors calculated
from the regulatory domain map. The refined catalytic domain was then
used in ten further IMR cycles. This process was carried out in the
10–3 Å resolution shell, resulting in significant improvements in the
interpretability of the regulatory domain. As sidechains became recog-
nizable, initially recognized sequence elements in several strands and
helices were extended to include connecting loops until the entire
domain was traced, with the exception of four loops, three of which
were built during the refinement phase. A more detailed description of
the IMR method is in preparation.
Refinement
The complete structure (both domains) was refined against 86% com-
plete data with Rsym = 0.07 in the resolution shell 16–2.8 Å by alternating
rounds of the program TNT [51] with model adjustments using the
program O [52]. The initial Rcryst value was 0.36 for a model containing
3507 nonhydrogen atoms out of the protein total of 3971. Rfree was mon-
itored [50] using 8% of the data; its value at the start of refinement was
0.43. After four rounds of positional refinement (each comprising about
40 cycles) the Rcryst and Rfree values had decreased to 0.23 and 0.35,
respectively. During the model adjustments between these refinement
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rounds, three of the four missing loops and several previously unresolved
sidechains were added, bringing the atom count to 3815. At this point
individual isotropic thermal parameters (B values) were refined, imposing
a tight B correlation for bonded atoms (TNT weight 20.0). Although the
number of reflections used in the refinement (13 356) was somewhat
less than the total number of parameters refined (x,y,z and B for 3815
atoms for a total of 15 260 refined parameters), the parameter values
were restrained (towards ideal geometry and B value correlation) so as to
reduce the effective parameter-to-observation ratio. After two more
rounds of refinement, 33 solvent molecules were added at difference
map maxima with reasonable contacts to the protein. The final model
lacks residues 1–4 at the N terminus and also lacks residues 481–496.
This missing zone in the regulatory domain corresponds to a highly
exposed connection between two b strands, where electron-density
maps show the presence of the polypeptide but are insufficiently ordered
to construct it. The distance between residues 480 and 497 and the
extent of the intervening weak density correspond reasonably well with
the number of missing residues, and there is no ambiguity about the
topology or fold. The final values of Rcryst and Rfree are 0.20 and 0.34,
respectively. Overall the model is of a quality consistent with other struc-
tures of its size and resolution, according to PROCHECK [53]. Rms devi-
ations from ideal parameters are 0.020 Å for bond lengths and 2.9° for
bond angles. 
Accession numbers
The coordinates for TD have been deposited in the Protein Data Bank
[54] with accession code 1tdj.
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